Zobrazeno 1 - 3
of 3
pro vyhledávání: '"SR de Kemp"'
Autor:
Marjanka K. Schmidt, B Nota, SR de Kemp, F.E. van Leeuwen, B Maertzdorf, L.J. van 't Veer, S G Klaver, R. de Groot, Vthbm Smit, A van der Plas, Raem Tollenaar, Annegien Broeks, Johannes L. Peterse, R Udo
Publikováno v:
Breast Cancer Research : BCR
Germline mutations in BRCA1 and BRCA2 account for approximately 2–3% of breast cancers while CHEK2*1100delC may account for an additional 0.7% [1]. To date, several small studies have suggested a worse outcome of survival in BRCA1 and BRCA2 carrier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a0cd1b77931c57cdc46db97cacb542c
https://doi.org/10.1186/bcr1094
https://doi.org/10.1186/bcr1094
Autor:
W Bakker, Marjanka K. Schmidt, Annegien Broeks, SR de Kemp, F.E. van Leeuwen, L.J. van 't Veer, Nicola S. Russell, Lfa Wessels, M Stovall, Linde M. Braaf
Publikováno v:
Breast Cancer Research : BCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5989edead7e1d0848c3855d8f9349896
http://europepmc.org/articles/PMC4233574
http://europepmc.org/articles/PMC4233574
Autor:
Schmidt MK; Department of Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT, Peterse JL, van Leeuwen FE, Van't Veer LJ
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2007 Jan 01; Vol. 25 (1), pp. 64-9. Date of Electronic Publication: 2006 Nov 28.